GSB Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
GSB Wealth Management's LLY Position: Q1 2026 in Review
GSB Wealth Management increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $13.2K and bringing the position to 1,223 shares worth $1.12M. The position accounts for 0.25% of the portfolio, ranked #96.
GSB Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.3M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- GSB Wealth Management held 1,223 shares of Eli Lilly worth $1.12M as of Q1 2026.
- GSB Wealth Management bought 13 Eli Lilly shares in Q1 2026, an estimated $13.2K.
- Eli Lilly made up 0.25% of GSB Wealth Management's portfolio in Q1 2026, its #96 holding.
- GSB Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- GSB Wealth Management's Eli Lilly position peaked at $1.3M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on GSB Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.